BCL2 and breast carcinoma: Therefore, in MCF-7 breast cancer cells, the simultaneous treatment of paclitaxel with curcumin exhibited synergistic growth inhibition through EGFR signaling modulation and induced significant apoptosis as demonstrated by bax increase and bcl-2 protein expression decrease [197].